Guan Lian

1.7k total citations
9 papers, 536 citations indexed

About

Guan Lian is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Guan Lian has authored 9 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Guan Lian's work include Immune cells in cancer (2 papers), Aortic Disease and Treatment Approaches (1 paper) and Adipokines, Inflammation, and Metabolic Diseases (1 paper). Guan Lian is often cited by papers focused on Immune cells in cancer (2 papers), Aortic Disease and Treatment Approaches (1 paper) and Adipokines, Inflammation, and Metabolic Diseases (1 paper). Guan Lian collaborates with scholars based in China, Romania and United Kingdom. Guan Lian's co-authors include Changtao Jiang, Xian Wang, Huiying Liu, Song‐Yang Zhang, Ting Wang, Linqi Zhang, Yanli Pang, Xiaopeng Li, Lulu Sun and Tao Zhang and has published in prestigious journals such as Biomacromolecules, Cell Reports and Atherosclerosis.

In The Last Decade

Guan Lian

9 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guan Lian China 7 241 206 126 102 63 9 536
Limei Wu China 14 341 1.4× 152 0.7× 153 1.2× 46 0.5× 104 1.7× 39 603
Eleonora Cianci Italy 10 203 0.8× 127 0.6× 77 0.6× 83 0.8× 45 0.7× 14 570
Wenhao Han China 14 378 1.6× 107 0.5× 69 0.5× 52 0.5× 38 0.6× 20 660
Criselda Mendoza-Milla Mexico 15 332 1.4× 116 0.6× 114 0.9× 152 1.5× 74 1.2× 34 673
Yuanyuan Meng China 14 298 1.2× 64 0.3× 196 1.6× 87 0.9× 53 0.8× 37 599
Mahmoud Al‐Azab China 12 273 1.1× 107 0.5× 80 0.6× 62 0.6× 42 0.7× 29 566
Liangliang Jia China 14 342 1.4× 119 0.6× 89 0.7× 90 0.9× 45 0.7× 31 671
Mario Picozza Italy 13 249 1.0× 142 0.7× 150 1.2× 26 0.3× 48 0.8× 27 714
Stuart Pearce United Kingdom 6 150 0.6× 177 0.9× 89 0.7× 156 1.5× 57 0.9× 9 495
Sayantan Jana Canada 14 186 0.8× 132 0.6× 80 0.6× 166 1.6× 58 0.9× 33 755

Countries citing papers authored by Guan Lian

Since Specialization
Citations

This map shows the geographic impact of Guan Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guan Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guan Lian more than expected).

Fields of papers citing papers by Guan Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guan Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guan Lian. The network helps show where Guan Lian may publish in the future.

Co-authorship network of co-authors of Guan Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Guan Lian. A scholar is included among the top collaborators of Guan Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guan Lian. Guan Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Li, Xiaopeng, Xiujuan Zhang, Jialin Xia, et al.. (2021). Macrophage HIF-2α suppresses NLRP3 inflammasome activation and alleviates insulin resistance. Cell Reports. 36(8). 109607–109607. 43 indexed citations
2.
Lian, Guan, et al.. (2021). Punicalagin Attenuates Disturbed Flow-Induced Vascular Dysfunction by Inhibiting Force-Specific Activation of Smad1/5. Frontiers in Cell and Developmental Biology. 9. 697539–697539. 7 indexed citations
3.
Cao, Yini, et al.. (2019). Atheroprotective Mechanisms of Tilianin by Inhibiting Inflammation Through Down-Regulating NF-κB Pathway and Foam Cells Formation. Frontiers in Physiology. 10. 825–825. 23 indexed citations
4.
Lian, Guan, Xiaopeng Li, Linqi Zhang, et al.. (2019). Macrophage metabolic reprogramming aggravates aortic dissection through the HIF1α-ADAM17 pathway✰. EBioMedicine. 49. 291–304. 101 indexed citations
5.
Wang, Ting, Huiying Liu, Guan Lian, et al.. (2017). HIF1α-Induced Glycolysis Metabolism Is Essential to the Activation of Inflammatory Macrophages. Mediators of Inflammation. 2017. 1–10. 283 indexed citations
6.
Lian, Guan, et al.. (2017). Study on hypolipidemic and anti-atherosclerosis effects of grapeseed polyphenols. Atherosclerosis. 263. e168–e168. 1 indexed citations
7.
Liu, Jia, et al.. (2017). An HPLC–MS/MS method for quantitation of Gly-MCA in mouse plasma: Application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 146. 53–58. 2 indexed citations
8.
Song, Jie, et al.. (2016). Arctigenin Treatment Protects against Brain Damage through an Anti-Inflammatory and Anti-Apoptotic Mechanism after Needle Insertion. Frontiers in Pharmacology. 7. 182–182. 32 indexed citations
9.
Yu, Maomao, Jie Xu, Lu Xu, et al.. (2015). Recent Advances in Dendrimer Research for Cardiovascular Diseases. Biomacromolecules. 16(9). 2588–2598. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026